JP2017538478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017538478A5 JP2017538478A5 JP2017526959A JP2017526959A JP2017538478A5 JP 2017538478 A5 JP2017538478 A5 JP 2017538478A5 JP 2017526959 A JP2017526959 A JP 2017526959A JP 2017526959 A JP2017526959 A JP 2017526959A JP 2017538478 A5 JP2017538478 A5 JP 2017538478A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- supply equipment
- nosepiece
- equipment according
- nasal valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101800000989 Oxytocin Proteins 0.000 claims 17
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 claims 16
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 claims 15
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 claims 15
- 229960001723 oxytocin Drugs 0.000 claims 15
- 239000005557 antagonist Substances 0.000 claims 13
- 229940127264 non-peptide agonist Drugs 0.000 claims 13
- 210000001331 nose Anatomy 0.000 claims 6
- 210000003928 nasal cavity Anatomy 0.000 claims 5
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims 4
- 108010004977 Vasopressins Proteins 0.000 claims 4
- 102000002852 Vasopressins Human genes 0.000 claims 4
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims 4
- 230000036470 plasma concentration Effects 0.000 claims 4
- 229960003726 vasopressin Drugs 0.000 claims 4
- 229920001971 elastomer Polymers 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 229920002725 thermoplastic elastomer Polymers 0.000 claims 2
- 208000011597 CGF1 Diseases 0.000 claims 1
- 229940083963 Peptide antagonist Drugs 0.000 claims 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 claims 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 108700021293 carbetocin Proteins 0.000 claims 1
- 229960001118 carbetocin Drugs 0.000 claims 1
- NSTRIRCPWQHTIA-DTRKZRJBSA-N carbetocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSCCCC(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(OC)C=C1 NSTRIRCPWQHTIA-DTRKZRJBSA-N 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 239000013013 elastic material Substances 0.000 claims 1
- 239000000806 elastomer Substances 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 239000003336 oxytocin antagonist Substances 0.000 claims 1
- 229940121361 oxytocin antagonists Drugs 0.000 claims 1
- 239000004033 plastic Substances 0.000 claims 1
- 229920003023 plastic Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229940098458 powder spray Drugs 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000011273 social behavior Effects 0.000 claims 1
- 230000004039 social cognition Effects 0.000 claims 1
- 210000001584 soft palate Anatomy 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 210000003901 trigeminal nerve Anatomy 0.000 claims 1
- HWPGRFRXZNLZEX-UHFFFAOYSA-N way-267,464 Chemical compound CC1=CC(C(=O)N2C3=CC=CC=C3NC=3N(C)N=CC=3C2)=CC=C1CNC(=O)N(CC1)CCN1CC1=CC(O)=CC(O)=C1 HWPGRFRXZNLZEX-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462081742P | 2014-11-19 | 2014-11-19 | |
| US62/081,742 | 2014-11-19 | ||
| PCT/EP2015/077162 WO2016079267A1 (en) | 2014-11-19 | 2015-11-19 | Intranasal administration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017538478A JP2017538478A (ja) | 2017-12-28 |
| JP2017538478A5 true JP2017538478A5 (enExample) | 2018-12-20 |
| JP6990583B2 JP6990583B2 (ja) | 2022-01-12 |
Family
ID=54695714
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017526959A Active JP6990583B2 (ja) | 2014-11-19 | 2015-11-19 | 鼻腔内投与 |
| JP2017526941A Active JP6937690B2 (ja) | 2014-11-19 | 2015-11-19 | 鼻腔内投与 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017526941A Active JP6937690B2 (ja) | 2014-11-19 | 2015-11-19 | 鼻腔内投与 |
Country Status (19)
| Country | Link |
|---|---|
| US (6) | US11052204B2 (enExample) |
| EP (3) | EP3733235B1 (enExample) |
| JP (2) | JP6990583B2 (enExample) |
| KR (2) | KR20170086599A (enExample) |
| CN (3) | CN111921046B (enExample) |
| AU (2) | AU2015348297A1 (enExample) |
| BR (2) | BR112017010522B1 (enExample) |
| CA (2) | CA2966802C (enExample) |
| DK (2) | DK3220988T3 (enExample) |
| ES (3) | ES2906984T3 (enExample) |
| HK (1) | HK1244729A1 (enExample) |
| IL (2) | IL251935A0 (enExample) |
| MX (2) | MX2017006265A (enExample) |
| MY (1) | MY188242A (enExample) |
| PL (1) | PL3220989T3 (enExample) |
| RU (2) | RU2714168C2 (enExample) |
| SG (2) | SG11201703792XA (enExample) |
| WO (2) | WO2016079271A1 (enExample) |
| ZA (1) | ZA201704149B (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0311570D0 (en) | 2003-05-20 | 2003-06-25 | Optinose As | Delivery device and method |
| GB0320171D0 (en) | 2003-08-28 | 2003-10-01 | Optinose As | Delivery devices |
| GB0420513D0 (en) | 2004-09-15 | 2004-10-20 | Optinose As | Powder delivery devices |
| GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
| GB0604444D0 (en) * | 2006-03-06 | 2006-04-12 | Optinose As | Nasal devices |
| GB0605799D0 (en) | 2006-03-23 | 2006-05-03 | Optinose As | Nasal delivery devices |
| GB2438834A (en) | 2006-06-08 | 2007-12-12 | Optinose As | Intranasal protein administration |
| GB2440316A (en) | 2006-07-25 | 2008-01-30 | Optinose As | Nasal inhaler with scrubber |
| GB0623731D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery device |
| GB0623732D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Powder delivery devices |
| GB0623728D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery devices |
| GB2448193A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal delivery device |
| GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
| GB0719299D0 (en) | 2007-10-03 | 2007-11-14 | Optinose As | Nasal delivery devices |
| US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
| SG10201600092UA (en) | 2012-02-24 | 2016-02-26 | Optinose As | Nasal Delivery Devices |
| USD761951S1 (en) | 2013-05-23 | 2016-07-19 | Optinose As | Nosepiece unit |
| JP6990583B2 (ja) | 2014-11-19 | 2022-01-12 | オプティノーズ アズ | 鼻腔内投与 |
| US10368502B2 (en) | 2017-09-25 | 2019-08-06 | Multiple Energy Technologies Llc | Bioceramic and carbon-based hydroponic systems, methods and devices |
| JP2021520266A (ja) | 2018-04-12 | 2021-08-19 | ロケット サイエンス ヘルス コープ． | 鼻腔内薬剤送達デバイス、システム、およびプロセス |
| KR102148613B1 (ko) * | 2019-01-28 | 2020-10-14 | 닉스 주식회사 | 이산화탄소를 이용한 수면 유도시스템 |
| CN110188836B (zh) * | 2019-06-21 | 2021-06-11 | 西安交通大学 | 一种基于变分自编码器的脑功能网络分类方法 |
| US20220313895A1 (en) * | 2019-08-14 | 2022-10-06 | Gsk Consumer Healthcare Sarl | Bi-material nozzle for nasal washes |
| US11241477B2 (en) | 2019-08-29 | 2022-02-08 | New York University | Oxytocin compositions for treatment of tinnitus |
| US20220161000A1 (en) * | 2020-11-24 | 2022-05-26 | Medtronic, Inc. | Multi-durometer attachment device for chronic fixation |
| CN112972879A (zh) * | 2021-04-20 | 2021-06-18 | 苏州新劢德医疗器械科技有限公司 | 流体分配设备 |
| CN112999499A (zh) * | 2021-04-20 | 2021-06-22 | 苏州新劢德医疗器械科技有限公司 | 流体分配设备 |
| CN114306207A (zh) * | 2021-12-30 | 2022-04-12 | 电子科技大学 | 一种以棒棒糖为载体的口腔给药方法 |
| US20230285278A1 (en) * | 2022-03-06 | 2023-09-14 | Optinose, Inc. | Methods for treating chronic rhinosinusitis |
| WO2025118074A1 (en) * | 2023-12-04 | 2025-06-12 | Rocket Science Health Corp. | Olfactory delivery of therapeutic peptides |
| WO2025174892A1 (en) * | 2024-02-13 | 2025-08-21 | Breathewave Technologies Inc. | Personalized-fit nasal dilator |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US605436A (en) | 1898-06-07 | Inhaler | ||
| US642748A (en) | 1899-02-23 | 1900-02-06 | Arthur Manners | Inhaler. |
| US658436A (en) | 1900-05-28 | 1900-09-25 | Hans Hennerich Groth | Insufflator. |
| US746749A (en) | 1903-03-18 | 1903-12-15 | George E Seidel | Nasal medicator. |
| US794641A (en) | 1905-03-06 | 1905-07-11 | Alfred H Ramey | Inhaler. |
| US902832A (en) | 1907-09-20 | 1908-11-03 | Edward F Philbrook | Inhaler. |
| KR100390480B1 (ko) | 1995-01-23 | 2003-10-04 | 디렉트-할러 아/에스 | 흡입기 |
| US5901703A (en) | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
| JP3320288B2 (ja) * | 1995-11-15 | 2002-09-03 | 株式会社ユニシアジェックス | 鼻腔用投薬器 |
| US5797392C1 (en) | 1996-01-22 | 2001-01-09 | Direct Haler As | Inhaler |
| US6648848B1 (en) | 1997-05-27 | 2003-11-18 | Direct-Haler A/S | Inhaler for powdered medicaments |
| GB9719775D0 (en) | 1997-09-18 | 1997-11-19 | Glaxo Group Ltd | Device |
| FR2771296B1 (fr) * | 1997-11-25 | 2000-03-10 | Sofab | Embout nasal avec fermeture d'extremite |
| GB0114272D0 (en) | 2001-06-12 | 2001-08-01 | Optinose As | Nasal delivery device |
| BR0008650B1 (pt) | 1999-03-03 | 2010-12-28 | dispositivo de transmissão via nasal. | |
| GB0121568D0 (en) | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
| US20070032410A1 (en) | 2000-01-11 | 2007-02-08 | Atossa Healthcare, Inc. | Compositions and methods for the treatment of psychiatric disorders |
| US6894026B1 (en) | 2000-01-11 | 2005-05-17 | Atossa Healthcare, Inc. | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders |
| GB0015309D0 (en) | 2000-06-21 | 2000-08-16 | Djupesland Per G | Apparatus |
| ZA200306564B (en) | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
| GB0207422D0 (en) | 2002-03-28 | 2002-05-08 | Optinose As | Nasal devices |
| GB0207817D0 (en) | 2002-04-04 | 2002-05-15 | Optinose As | Nasal devices |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| GB0215270D0 (en) | 2002-07-02 | 2002-08-14 | Optinose As | Nasal devices |
| GB0215904D0 (en) | 2002-07-09 | 2002-08-21 | Team Holdings Uk Ltd | Drug delivery system and method |
| GB0300008D0 (en) | 2003-01-02 | 2003-02-05 | Optinose As | Delivery devices |
| GB2400565B (en) | 2003-04-17 | 2005-03-02 | Bespak Plc | Nasal drug delivery |
| GB0311570D0 (en) | 2003-05-20 | 2003-06-25 | Optinose As | Delivery device and method |
| GB0319119D0 (en) | 2003-08-14 | 2003-09-17 | Optinose As | Delivery devices |
| GB0320171D0 (en) | 2003-08-28 | 2003-10-01 | Optinose As | Delivery devices |
| GB0405477D0 (en) | 2004-03-11 | 2004-04-21 | Glaxo Group Ltd | A fluid dispensing device |
| USD530815S1 (en) | 2004-03-19 | 2006-10-24 | Optinose As | Nasal delivery device |
| GB0420513D0 (en) | 2004-09-15 | 2004-10-20 | Optinose As | Powder delivery devices |
| GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
| EP1928484B1 (en) | 2005-08-26 | 2010-02-24 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treatment of headaches by administration of oxytocin |
| JP4765526B2 (ja) | 2005-10-04 | 2011-09-07 | オムロンヘルスケア株式会社 | 吸入器および吸入器用マウスピース |
| EP1984049A1 (en) | 2006-01-19 | 2008-10-29 | Optinose AS | Nasal administration |
| EP1988953B1 (en) | 2006-02-14 | 2017-07-19 | Optinose AS | Delivery device |
| GB0602980D0 (en) | 2006-02-14 | 2006-03-29 | Optinose As | Delivery device and method |
| GB0604319D0 (en) | 2006-03-03 | 2006-04-12 | Optinose As | Nasal delivery |
| GB0604444D0 (en) * | 2006-03-06 | 2006-04-12 | Optinose As | Nasal devices |
| GB0605799D0 (en) | 2006-03-23 | 2006-05-03 | Optinose As | Nasal delivery devices |
| GB2437488A (en) | 2006-04-25 | 2007-10-31 | Optinose As | Pharmaceutical oily formulation for nasal or buccal administration |
| GB2438834A (en) | 2006-06-08 | 2007-12-12 | Optinose As | Intranasal protein administration |
| GB2440316A (en) | 2006-07-25 | 2008-01-30 | Optinose As | Nasal inhaler with scrubber |
| JP2008062974A (ja) * | 2006-09-07 | 2008-03-21 | Mitani Valve Co Ltd | 内容物放出用容器ならびに、この内容物放出用容器を備えたポンプ式製品およびエアゾール式製品 |
| GB0623731D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery device |
| GB0623728D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery devices |
| GB0623732D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Powder delivery devices |
| US20100199984A1 (en) | 2007-04-02 | 2010-08-12 | Abbott Laboratories | Breath actuated nasal pump |
| GB2448193A (en) * | 2007-04-05 | 2008-10-08 | Optinose As | Nasal delivery device |
| GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
| US8342173B2 (en) | 2007-07-19 | 2013-01-01 | Silver Eagle Labs Inc. | Nasal dilator with cushion layer and variable spring rate |
| GB0719299D0 (en) * | 2007-10-03 | 2007-11-14 | Optinose As | Nasal delivery devices |
| EP3272379A1 (en) | 2008-02-07 | 2018-01-24 | The University of Washington | Circumferential aerosol device |
| EP2242526A4 (en) | 2008-02-15 | 2014-06-18 | Timothy Sean Immel | AEROSOL TREATMENT DEVICE WITH HIGH FREQUENCY ADMINISTRATION |
| US20110318345A1 (en) | 2008-09-15 | 2011-12-29 | Optinose As | Nasal delivery |
| GB201015371D0 (en) | 2010-09-14 | 2010-10-27 | Optinose As | Nasal delivery |
| GB201020638D0 (en) * | 2010-12-06 | 2011-01-19 | Liconsa Laboratorios Sa | Inhalator |
| US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
| RU112044U1 (ru) * | 2011-08-25 | 2012-01-10 | Наиль Минрахманович Нуртдинов | Тренажер-ингалятор |
| SG10201600092UA (en) | 2012-02-24 | 2016-02-26 | Optinose As | Nasal Delivery Devices |
| JP6382723B2 (ja) | 2012-02-24 | 2018-08-29 | オプティノーズ アズ | 経鼻配送装置 |
| JP6286367B2 (ja) | 2012-02-24 | 2018-02-28 | オプティノーズ アズ | 経鼻配送装置 |
| BR112015024869A8 (pt) * | 2013-03-26 | 2019-12-17 | Optinose As | uso de um agente terapêutico e/ou de diôxido de carbono para tratar um paciente e aparelhos e métodos para tratar terapeuticamente um paciente |
| US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
| USD761951S1 (en) | 2013-05-23 | 2016-07-19 | Optinose As | Nosepiece unit |
| USD725769S1 (en) | 2013-05-23 | 2015-03-31 | Optinose As | Nasal delivery device |
| USD723156S1 (en) | 2013-05-23 | 2015-02-24 | Optinose As | Nasal delivery device |
| JP6990583B2 (ja) | 2014-11-19 | 2022-01-12 | オプティノーズ アズ | 鼻腔内投与 |
| US20220296825A1 (en) | 2018-10-04 | 2022-09-22 | Optinose As | Exhalation delivery system for and method of treating sinus disease |
-
2015
- 2015-11-19 JP JP2017526959A patent/JP6990583B2/ja active Active
- 2015-11-19 WO PCT/EP2015/077166 patent/WO2016079271A1/en not_active Ceased
- 2015-11-19 CN CN202010816000.4A patent/CN111921046B/zh active Active
- 2015-11-19 BR BR112017010522-5A patent/BR112017010522B1/pt not_active IP Right Cessation
- 2015-11-19 DK DK15798058.2T patent/DK3220988T3/da active
- 2015-11-19 RU RU2017114951A patent/RU2714168C2/ru active
- 2015-11-19 ES ES15798058T patent/ES2906984T3/es active Active
- 2015-11-19 EP EP20181431.6A patent/EP3733235B1/en active Active
- 2015-11-19 RU RU2017114950A patent/RU2017114950A/ru not_active Application Discontinuation
- 2015-11-19 KR KR1020177016766A patent/KR20170086599A/ko not_active Withdrawn
- 2015-11-19 PL PL15798061.6T patent/PL3220989T3/pl unknown
- 2015-11-19 CA CA2966802A patent/CA2966802C/en active Active
- 2015-11-19 CN CN201580062178.1A patent/CN107106792B/zh active Active
- 2015-11-19 AU AU2015348297A patent/AU2015348297A1/en not_active Abandoned
- 2015-11-19 EP EP15798061.6A patent/EP3220989B1/en active Active
- 2015-11-19 CA CA2966797A patent/CA2966797C/en active Active
- 2015-11-19 CN CN201580062083.XA patent/CN106999684B/zh active Active
- 2015-11-19 ES ES15798061T patent/ES2813442T3/es active Active
- 2015-11-19 WO PCT/EP2015/077162 patent/WO2016079267A1/en not_active Ceased
- 2015-11-19 HK HK18104123.2A patent/HK1244729A1/zh unknown
- 2015-11-19 MX MX2017006265A patent/MX2017006265A/es unknown
- 2015-11-19 JP JP2017526941A patent/JP6937690B2/ja active Active
- 2015-11-19 SG SG11201703792XA patent/SG11201703792XA/en unknown
- 2015-11-19 AU AU2015348301A patent/AU2015348301B2/en active Active
- 2015-11-19 ES ES20181431T patent/ES2949052T3/es active Active
- 2015-11-19 US US14/946,389 patent/US11052204B2/en active Active
- 2015-11-19 DK DK15798061.6T patent/DK3220989T3/da active
- 2015-11-19 EP EP15798058.2A patent/EP3220988B1/en active Active
- 2015-11-19 MY MYPI2017701760A patent/MY188242A/en unknown
- 2015-11-19 KR KR1020177016768A patent/KR20170085121A/ko not_active Ceased
- 2015-11-19 MX MX2017006268A patent/MX383241B/es unknown
- 2015-11-19 BR BR112017010561A patent/BR112017010561A2/pt not_active Application Discontinuation
- 2015-11-19 SG SG11201703794TA patent/SG11201703794TA/en unknown
- 2015-11-19 US US14/946,442 patent/US10940277B2/en active Active
-
2017
- 2017-04-26 IL IL251935A patent/IL251935A0/en unknown
- 2017-04-26 IL IL251936A patent/IL251936B/en active IP Right Grant
- 2017-06-15 ZA ZA2017/04149A patent/ZA201704149B/en unknown
-
2021
- 2021-01-29 US US17/162,475 patent/US11707586B2/en active Active
- 2021-06-04 US US17/338,962 patent/US11730904B2/en active Active
-
2023
- 2023-06-05 US US18/205,580 patent/US20230372647A1/en not_active Abandoned
-
2024
- 2024-09-19 US US18/889,476 patent/US20250114543A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017538478A5 (enExample) | ||
| RU2017114950A (ru) | Интраназальное введение | |
| JP2017538477A5 (enExample) | ||
| JP6509816B2 (ja) | 患者インタフェース装置 | |
| US12296100B2 (en) | Conforming nasal pillow | |
| US10398868B2 (en) | Nasal prong and patient interface device including the same | |
| CN106572917B (zh) | 鼻扩张器装置 | |
| US20120048265A1 (en) | Aerosol drug delivery apparatus and method | |
| US20140360499A1 (en) | Intranasal Airway Device | |
| US20150013677A1 (en) | Nasal Delivery Devices | |
| US10912908B2 (en) | Respiratory interface | |
| PH12017500460A1 (en) | Therapeutic agent delivery device with advanceable cannula and needle | |
| WO2014144717A3 (en) | Medical breathing apparatus | |
| TWI577398B (zh) | 咬嘴和吸氣器 | |
| CN104428025A (zh) | 鼻部递送装置 | |
| BR112013006254B1 (pt) | Câmara de inalação valvulada | |
| WO2014205093A3 (en) | Nasal spray delivery guide | |
| AR113942A1 (es) | Formulación farmacéutica que comprende surfactantes pulmonares para administración por nebulización | |
| CO2021007141A2 (es) | Composiciones inhalables para usarse en el tratamiento de enfermedades pulmonares | |
| US10376667B2 (en) | Intranasal airway device | |
| JP2019500974A (ja) | 経鼻粉体投与装置 | |
| RU2017136816A (ru) | Устройство для введения в ингалятор вкусового ароматизирующего вещества | |
| RU2016114403A (ru) | Способ и система для введения легочного сурфактанта путем пульверизации | |
| CN104703648B (zh) | 使用安装的插塞插入件的可定制衬垫 | |
| CN105813497B (zh) | 美容面罩 |